comparemela.com

Latest Breaking News On - Candidemia caused - Page 1 : comparemela.com

Basilea announces acquisition of fosmanogepix, a phase-3-ready broad-spectrum antifungal

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 13, 2023 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting.

Basel stadtSwitzerland generalUnited statesDavid veitchCresemba zevteraNils schrDrug administrationAmplyx pharmaceuticals incSwiss exchangeHead of corporate communications investor relationsAmerican thoracic societyBasilea pharmaceutica international ltdBasilea pharmaceutica ltdPfizer incPharmaceutica ltdAmplyx pharmaceuticals

Basilea announces acquisition of fosmanogepix, a

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 13, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a.

Basel stadtUnited statesSwitzerland generalNils schrCresemba zevteraDavid veitchDrug administrationSwiss exchangeAmplyx pharmaceuticals incAmerican thoracic societyHead of corporate communications investor relationsPfizer incBasilea pharmaceutica ltdBasilea pharmaceutica international ltdPharmaceutica ltdAmplyx pharmaceuticals

vimarsana © 2020. All Rights Reserved.